These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 59781)

  • 1. Cold activation of complement i. presence of coagulation-related activator.
    Kondo M; Hosokawa K; Masuda M
    J Immunol; 1976 Aug; 117(2):486-90. PubMed ID: 59781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cold activation of the classical complement pathway: The cause of the differences between plasma and serum complement in liver cirrhosis.
    Kitamura H; Nagaki K; Inoshita K; Iida K; Inai S
    Clin Exp Immunol; 1977 Jan; 27(1):34-7. PubMed ID: 849648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors.
    Derkx FH; Bouma BN; Schalekamp MA
    J Lab Clin Med; 1984 Apr; 103(4):560-73. PubMed ID: 6366096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-1 inactivator and cold-promoted activation of factor VII.
    van Royen EA; Lohman S; Voss M; Pondman KW
    J Lab Clin Med; 1978 Aug; 92(2):152-63. PubMed ID: 681808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cold activation of complement for monitoring the response to interferon in patients with chronic hepatitis C.
    Akahane Y; Miyazaki Y; Naitoh S; Takeda K; Tsuda F; Okamoto H; Itoh K; Miyakawa Y; Mayumi M
    Am J Gastroenterol; 1996 Feb; 91(2):319-27. PubMed ID: 8607500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H; Ratnoff OD
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of coagulation and fibrinolysis by plasma proteinase inhibitors.
    Travis J; Salvesen G
    Behring Inst Mitt; 1983 Aug; (73):56-65. PubMed ID: 6206838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cold promoted activation and factor XII, prekallikrein and C1-inhibitor.
    Czendlik C; Lämmle B; Duckert F
    Thromb Haemost; 1985 Apr; 53(2):242-4. PubMed ID: 2410997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between plasma and serum complement in patients with chronic liver disease.
    Inai S; Kitamura H; Fujita T; Kojima J; Nagaki K
    Clin Exp Immunol; 1976 Sep; 25(3):403-9. PubMed ID: 963909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme activation and inhibition induced by cold provocation in a patient with cold urticaria.
    Martens PM; Berrens L
    Acta Derm Venereol; 1975; 55(2):121-5. PubMed ID: 48315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease inhibitors in plasma of patients with chronic urticaria.
    Doeglas HM; Bleumink E
    Arch Dermatol; 1975 Aug; 111(8):979-85. PubMed ID: 60915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rheumatoid factor and cryoglobulin are not efficiently related to cold activation of complement].
    Nakagawa T; Ueda K; Nakajima H; Shimizu A
    Rinsho Byori; 1995 Jan; 43(1):21-5. PubMed ID: 7884960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum concentrations of proteinase inhibitors, complement components and of acid alpha-1-glucoprotein in children with myocarditis (author's transl)].
    Lubec G; Schlemmer M; Wimmer M
    Klin Padiatr; 1977 Jul; 189(4):253-8. PubMed ID: 70547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic and antigenic measurements of complement. A comparison of serum and plasma samples in normal individuals and patients.
    Newell S; Gorman JC; Bell E; Atkinson JP
    J Lab Clin Med; 1982 Sep; 100(3):437-44. PubMed ID: 7108352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of cold activation of transfusion plasma during storage at +4 degrees C.
    Suontaka AM; Silveira A; Söderström T; Blombäck M
    Vox Sang; 2005 Apr; 88(3):172-80. PubMed ID: 15787727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of augmented Hageman factor (factor XII) titers in the cold-promoted activation of factor VII and spontaneous shortening of the prothrombin time in women using oral contraceptives.
    Gordon EM; Ratnoff OD; Jones PK
    J Lab Clin Med; 1982 Mar; 99(3):363-9. PubMed ID: 7057063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on contact activation: effects of surface and inhibitors.
    Cameron CL; Fisslthaler B; Sherman A; Reddigari S; Silverberg M
    Med Prog Technol; 1989; 15(1-2):53-62. PubMed ID: 2530427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording.
    Joist JH; Cowan JF; Khan M
    J Lab Clin Med; 1977 Dec; 90(6):1054-65. PubMed ID: 303667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study of coagulation contact factors in hereditary angioneurotic oedema (author's transl)].
    Soulier JP; Gozin D; Ollier-Hartmann MP; Hartmann L
    Nouv Presse Med; 1981 May; 10(20):1627-31. PubMed ID: 6166918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.